Statin therapy for elevated hsCRP: more evidence is needed.
Molokwu
Ogochukwu C
OC
Community Medical Centers, Fresno, CA 93701, USA. omolokwu@communitymedical.org
D000924:Anticholesteremic Agents / Q000191:economics / Q000627:therapeutic use*; D002097:C-Reactive Protein / Q000032:analysis / Q000187:drug effects*; D003324:Coronary Artery Disease / Q000188:drug therapy* / Q000191:economics; D019317:Evidence-Based Medicine; D005464:Fluorobenzenes / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics / Q000627:therapeutic use*; D011743:Pyrimidines / Q000191:economics / Q000627:therapeutic use*; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000191:economics / Q000627:therapeutic use*; D014481:United States
D000924:Anticholesteremic Agents; D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium; D002097:C-Reactive Protein